Page last updated: 2024-10-25

clonidine and Conduct Disorder

clonidine has been researched along with Conduct Disorder in 5 studies

Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.

Conduct Disorder: A repetitive and persistent pattern of behavior in which the basic rights of others or major age-appropriate societal norms or rules are violated. These behaviors include aggressive conduct that causes or threatens physical harm to other people or animals, nonaggressive conduct that causes property loss or damage, deceitfulness or theft, and serious violations of rules. The onset is before age 18. (From DSM-IV, 1994)

Research Excerpts

ExcerptRelevanceReference
"A pilot comparison of the safety and efficacy of methylphenidate (MPH) combined with clonidine, clonidine monotherapy, or MPH monotherapy in 6- to 16-year-old children diagnosed with attention deficit hyperactivity disorder (ADHD) and comorbid aggressive oppositional defiant disorder or conduct disorder was completed."9.09A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. ( Barkley, RA; Connor, DF; Davis, HT, 2000)
"A pilot comparison of the safety and efficacy of methylphenidate (MPH) combined with clonidine, clonidine monotherapy, or MPH monotherapy in 6- to 16-year-old children diagnosed with attention deficit hyperactivity disorder (ADHD) and comorbid aggressive oppositional defiant disorder or conduct disorder was completed."5.09A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. ( Barkley, RA; Connor, DF; Davis, HT, 2000)
"Although the neurochemistry of Tourette's disorder is not well known, there are some effective therapies for tics, OCD and ADHD."2.41Pharmacological options for the treatment of Tourette's disorder. ( García-Ruiz, PJ; Jiménez-Jiménez, FJ, 2001)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Efron, D1
Lycett, K1
Sciberras, E1
Gérardin, P1
Cohen, D1
Mazet, P1
Flament, MF1
Weller, EB1
Rowan, A1
Elia, J1
Weller, RA1
Connor, DF1
Barkley, RA1
Davis, HT1
Jiménez-Jiménez, FJ1
García-Ruiz, PJ1

Reviews

2 reviews available for clonidine and Conduct Disorder

ArticleYear
Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders.
    The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 15

    Topics: Adolescent; Aggression; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Child; Child D

1999
Pharmacological options for the treatment of Tourette's disorder.
    Drugs, 2001, Volume: 61, Issue:15

    Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Botulinum

2001

Trials

2 trials available for clonidine and Conduct Disorder

ArticleYear
Use of sleep medication in children with ADHD.
    Sleep medicine, 2014, Volume: 15, Issue:4

    Topics: Adolescent; Anxiety Disorders; Attention Deficit and Disruptive Behavior Disorders; Attention Defici

2014
A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder.
    Clinical pediatrics, 2000, Volume: 39, Issue:1

    Topics: Adolescent; Adrenergic alpha-Agonists; Aggression; Attention Deficit Disorder with Hyperactivity; Ce

2000

Other Studies

1 other study available for clonidine and Conduct Disorder

ArticleYear
Drug treatment of conduct disorder in young people.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2002, Volume: 12, Issue:5

    Topics: Adolescent; Adrenergic alpha-Agonists; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Central

2002